Akrotome Imaging, Inc. news

Akrotome Co-Founder, Dr. Jim Basilion, traveled to Europe to make invited presentations in November, 2018. Dr. Basilion delivered papers focused on the use of molecular probes for guided, precision surgery to the European Society of Molecular Imaging, the World Society of Molecular Imaging, and the Netherlands Science Academy.

Akrotome CEO accepts invitation to be a reviewer for NCI Bridge Award applications.
Dr. Brian Straight, President and CEO of Akrotome, has accepted an invitation to be a reviewer for the National Cancer Institute’s Bridge Award Program, which seeks to provide funding for promising small businesses that have successfully completed their Phase I and Phase II contracts, and are in the advanced development stage of their technology leading up to commercialization. Dr.

Akrotome Co-Founder Dr. James Basilion attended the World Molecular Imaging Congress/National Cancer Institute workshop in Washington DC.

The workshop included participants from FDA and the Centers for Medicare & Medicaid Services (CMS). Focused on the PET/ultrasound/optical agent approval process, the invitation-only workshop was atten

Akrotome receives grant for the commercialization of a topical probe for margin determination in skin cancers

Akrotome Imaging has received a $1.77M SBIR Phase II grant to assist in the clinical translation of its FIRE™ probe for margin assessment in skin cancer.

In this application, FIRE is applied ex-vivo to skin tissue that has been surgically removed.  When the pro